About Pathogenetix
Pathogenetix is a company based in Woburn (United States) founded in 1997. It operates as a B2B. Pathogenetix has raised $28.01 million across 7 funding rounds from investors including Excel Venture Management, Healthcare Ventures and Ascension Ventures. The company has 29 employees as of December 31, 2013. Pathogenetix operates in a competitive market with competitors including Nanopore, PacBio, OpGen, Omniome and Complete Genomics, among others.
- Headquarter Woburn, United States
- Employees 29 as on 31 Dec, 2013
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.01 M (USD)
in 7 rounds
-
Latest Funding Round
$10 M (USD), Series C
Oct 15, 2013
-
Investors
Excel Venture Management
& 2 more
-
Employee Count
29
as on Dec 31, 2013
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pathogenetix
Pathogenetix has successfully raised a total of $28.01M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in October 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pathogenetix
Pathogenetix has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Excel Venture Management, Healthcare Ventures and Ascension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early to late stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked |
Investor details for Pathogenetix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pathogenetix
Investment portfolio details for Pathogenetix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pathogenetix
Detailed financials for Pathogenetix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pathogenetix Comparisons
Peer comparison for Pathogenetix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pathogenetix
Pathogenetix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, OpGen, Omniome and Complete Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
Detailed competitors of Pathogenetix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pathogenetix
Complete news archive for Pathogenetix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pathogenetix
Pathogenetix was founded in 1997 and raised its 1st funding round 13 years after it was founded.
Pathogenetix is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Pathogenetix is a funded company, having raised a total of $28.01M across 7 funding rounds to date.
As of Dec 31, 2013, the latest employee count at Pathogenetix is 29.
Pathogenetix, based in Woburn, focuses on advancing biotech innovations, medical technology, offering diagnostic solutions, and bacterial analysis. Develops innovative technologies for automated bacterial strain typing from complex samples. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Pathogenetix has 3 investors. Key investors include Excel Venture Management, Healthcare Ventures, and Ascension Ventures.